Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11052088 Kinase inhibitor salts, and compositions thereof

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

July 6, 2021

Patent Application Number

17167719

Date Filed

February 4, 2021

Patent Citations

US Patent 10023566 Dasatinib salts

US Patent 10034873 C-met modulator pharmaceutical compositions

US Patent 10039757 C-Met modulator pharmaceutical compositions

US Patent 10052307 Micellar nanocomplex

US Patent 10076520 Use of tyrosine kinase inhibitor in cancer treatment

US Patent 10080723 Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same

US Patent 10105323 Pharmaceutical dosage form for immediate release of an indolinone derivative

US Patent 10117881 Protective effect of DMPC, DMPG, DMPC/DMPG, LYSOPG and LYSOPC against drugs that cause channelopathies

...

Patent Citations Received

US Patent 12064430 Kinase inhibitor salts and compositions thereof

0

Patent Primary Examiner

Patent abstract

The present invention relates to polymorphic forms of dasatinib lauryl sulfate salt.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11052088 Kinase inhibitor salts, and compositions thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool